Literature DB >> 29016315

Case Report: Molecular Confirmation of Lobomycosis in an Italian Traveler Acquired in the Amazon Region of Venezuela.

Anna Beltrame1, Patrizia Danesi2, Claudio Farina3, Pierantonio Orza1, Francesca Perandin1, Claudia Zanardello2, Paola Rodari1, Silvia Staffolani1, Zeno Bisoffi1.   

Abstract

Lobomycosis is a chronic skin mycosis endemic in Amazon regions characterized by chronic nodular or keloidal lesions caused by Lacazia loboi, an uncultivable fungus. Imported cases in nonendemic countries are rare and diagnosed after years. We describe a case of lobomycosis in a healthy 55-year-old Italian traveler who had acquired the infection during 5-day-honeymoon in the Amazon region of Venezuela in 1999. Several weeks after return, he recalled pruritus and papular skin lesions on the left lower limb, subsequently evolving to a plaque-like lesion. Blastomycosis and cryptococcosis were hypothesized based on microscopic morphology of yeast-like bodies found in three consecutive biopsies, although fungal cultures were always negative. In 2016, exfoliative cytology and a biopsy specimen examination showed round yeast-like organisms (6-12 μm), isolated or in a chain, connected by short tubular projections fulfilling the morphologic diagnostic criteria of Lacazia spp. The microscopic diagnosis was confirmed by molecular identification.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29016315      PMCID: PMC5805066          DOI: 10.4269/ajtmh.17-0446

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Ten years experience with Jorge Lobo's disease in the state of Acre, Amazon region, Brazil.

Authors:  William John Woods; Andréa de Faria Fernandes Belone; Léia Borges Carneiro; Patrícia Sammarco Rosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2010 Sep-Oct       Impact factor: 1.846

2.  [Sucessful treatment with clofazimine and itraconazole in a 46 year old patient after 32 years duration of disease].

Authors:  M Fischer; A Chrusciak Talhari; D Reinel; S Talhari
Journal:  Hautarzt       Date:  2002-10       Impact factor: 0.751

3.  Anergic cutaneous leishmaniasis versus lobomycosis.

Authors:  K Nalovic; R A Pradinaud
Journal:  Int J Dermatol       Date:  1996-06       Impact factor: 2.736

4.  Lobomycosis. An electronmicroscopic, histochemical and immunologic study.

Authors:  J Bhawan; R W Bain; D T Purtilo; N Gomez; C Dewan; C F Whelan; S M Dolorum; L Edelstein
Journal:  J Cutan Pathol       Date:  1976       Impact factor: 1.587

Review 5.  Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.

Authors:  Flavio Queiroz-Telles; Marcio Nucci; Arnaldo Lopes Colombo; Angela Tobón; Angela Restrepo
Journal:  Med Mycol       Date:  2010-12-03       Impact factor: 4.076

6.  Phylogenetic analysis of Lacazia loboi places this previously uncharacterized pathogen within the dimorphic Onygenales.

Authors:  R A Herr; E J Tarcha; P R Taborda; J W Taylor; L Ajello; L Mendoza
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  [Lobomycosis: a mycosis seldom observed in metropolitan France].

Authors:  P Saint-Blancard; F Maccari; T Le Guyadec; G Lanternier; R Le Vagueresse
Journal:  Ann Pathol       Date:  2000-05       Impact factor: 0.407

8.  Report of the first human case of lobomycosis in the United States.

Authors:  R A Burns; J S Roy; C Woods; A A Padhye; D W Warnock
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

9.  Lobomycosis: A case from Southeastern Europe and review of the literature.

Authors:  Evangelia Papadavid; Maria Dalamaga; Irini Kapniari; Ekaterini Pantelidaki; Sotirios Papageorgiou; Vassiliki Pappa; Panagiotis Tsirigotis; Ioannis Dervenoulas; Nikolaos Stavrianeas; Dimitrios Rigopoulos
Journal:  J Dermatol Case Rep       Date:  2012-09-28

Review 10.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

View more
  4 in total

Review 1.  Lobomycosis Epidemiology and Management: The Quest for a Cure for the Most Neglected of Neglected Tropical Diseases.

Authors:  Franciely G Gonçalves; Patrícia S Rosa; Andrea de F F Belone; Léia B Carneiro; Vania L Q de Barros; Rosineide F Bispo; Yally A da S Sbardelott; Sebastião A V M Neves; Amy Y Vittor; William J Woods; Gabriel Z Laporta
Journal:  J Fungi (Basel)       Date:  2022-05-10

2.  Lobomycosis in Soldiers, Colombia.

Authors:  Claudia M Arenas; Gerzain Rodriguez-Toro; Andrea Ortiz-Florez; Ingrid Serrato
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

3.  Epidemiologic and Clinical Progression of Lobomycosis among Kaiabi Indians, Brazil, 1965-2019.

Authors:  Marcos C Florian; Douglas A Rodrigues; Sofia B M de Mendonça; Arnaldo L Colombo; Jane Tomimori
Journal:  Emerg Infect Dis       Date:  2020-05       Impact factor: 6.883

4.  The taxonomy of two uncultivated fungal mammalian pathogens is revealed through phylogeny and population genetic analyses.

Authors:  Raquel Vilela; Marianne Huebner; Camila Vilela; Gabriella Vilela; Bruno Pettersen; Claudia Oliveira; Leonel Mendoza
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.